Novartis trial shows no benefits from Pear’s schizophrenia app as CEO cites trial irregularities

Medical Devices

Published on: January 13, 2021 5:59 pm

The results will not impact the current rollout of a new version of the app, under special FDA guidelines.

Read more Source: mobihealthnews.com

Related Posts